Identifying obstacles hindering the conduct of academic-sponsored trials for drug repurposing on rare-diseases: an analysis of six use cases

por del Álamo, Marta, Bührer, Christoph, Fisher, Dirk, Griese, Matthias, Lingor, Paul, Palladini, Giovanni, Sireau, Nicolas, Hivert, Virginie, Sangiorgi, Luca, Guillot, Florence, Halftermeyer, Juliane, Soucková, Lenka, Nosková, Kristýna, Demlová, Regina
Publicado 2022

Minimal Residual Disease–Guided Intermittent Dosing in Patients With Cancer: Successful Treatment of Chemoresistant Anaplastic Large Cell Lymphoma Using Intermittent Lorlatinib Dos...

por Pokorna, Petra, Lakka Klement, Giannoula, Vasikova, Alzbeta, Kanderova, Veronika, Jezova, Marta, Noskova, Kristyna, Mudry, Peter, Kyr, Michal, Merta, Tomas, Bajciova, Viera, Krenova, Zdenka, Palova, Hana, Valik, Dalibor, Zdrazilova Dubska, Lenka, Slaby, Ondrej, Sterba, Jaroslav
Publicado 2022